nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Leflunomide—rheumatoid arthritis	0.00189	0.563	CbGbCtD
Epoprostenol—CYP2C9—Cyclosporine—rheumatoid arthritis	0.000886	0.263	CbGbCtD
Epoprostenol—CYP2C9—Dexamethasone—rheumatoid arthritis	0.000583	0.173	CbGbCtD
Epoprostenol—Shock—Methylprednisolone—rheumatoid arthritis	0.000547	0.00103	CcSEcCtD
Epoprostenol—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000545	0.00102	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Epistaxis—Methotrexate—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Rash—Leflunomide—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000544	0.00102	CcSEcCtD
Epoprostenol—Dermatitis—Leflunomide—rheumatoid arthritis	0.000543	0.00102	CcSEcCtD
Epoprostenol—Mental disorder—Prednisone—rheumatoid arthritis	0.000543	0.00102	CcSEcCtD
Epoprostenol—Nausea—Azathioprine—rheumatoid arthritis	0.000542	0.00102	CcSEcCtD
Epoprostenol—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000542	0.00102	CcSEcCtD
Epoprostenol—Headache—Leflunomide—rheumatoid arthritis	0.00054	0.00102	CcSEcCtD
Epoprostenol—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.00054	0.00101	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000539	0.00101	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000538	0.00101	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000537	0.00101	CcSEcCtD
Epoprostenol—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000535	0.00101	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000531	0.000998	CcSEcCtD
Epoprostenol—Urticaria—Cyclosporine—rheumatoid arthritis	0.000529	0.000994	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—rheumatoid arthritis	0.000527	0.000991	CcSEcCtD
Epoprostenol—Myalgia—Betamethasone—rheumatoid arthritis	0.000527	0.000991	CcSEcCtD
Epoprostenol—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000526	0.000989	CcSEcCtD
Epoprostenol—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000526	0.000989	CcSEcCtD
Epoprostenol—Anxiety—Dexamethasone—rheumatoid arthritis	0.000525	0.000987	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—rheumatoid arthritis	0.000525	0.000987	CcSEcCtD
Epoprostenol—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000521	0.000979	CcSEcCtD
Epoprostenol—Haemoglobin—Methotrexate—rheumatoid arthritis	0.00052	0.000978	CcSEcCtD
Epoprostenol—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000519	0.000976	CcSEcCtD
Epoprostenol—Pain—Prednisolone—rheumatoid arthritis	0.000518	0.000973	CcSEcCtD
Epoprostenol—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000518	0.000973	CcSEcCtD
Epoprostenol—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000514	0.000966	CcSEcCtD
Epoprostenol—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000514	0.000966	CcSEcCtD
Epoprostenol—Nausea—Leflunomide—rheumatoid arthritis	0.000512	0.000963	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000511	0.00096	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—rheumatoid arthritis	0.00051	0.000958	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000508	0.000954	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000506	0.000952	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—rheumatoid arthritis	0.000506	0.000951	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000505	0.00095	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—rheumatoid arthritis	0.000505	0.00095	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000505	0.00095	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—rheumatoid arthritis	0.000505	0.00095	CcSEcCtD
Epoprostenol—Insomnia—Triamcinolone—rheumatoid arthritis	0.000504	0.000947	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000503	0.000945	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—rheumatoid arthritis	0.000502	0.000944	CcSEcCtD
Epoprostenol—Infection—Betamethasone—rheumatoid arthritis	0.000502	0.000944	CcSEcCtD
Epoprostenol—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.0005	0.00094	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000499	0.000938	CcSEcCtD
Epoprostenol—Anaemia—Prednisone—rheumatoid arthritis	0.000498	0.000937	CcSEcCtD
Epoprostenol—Shock—Dexamethasone—rheumatoid arthritis	0.000497	0.000934	CcSEcCtD
Epoprostenol—Shock—Betamethasone—rheumatoid arthritis	0.000497	0.000934	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000497	0.000933	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000496	0.000931	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000496	0.000931	CcSEcCtD
Epoprostenol—Agitation—Prednisone—rheumatoid arthritis	0.000496	0.000931	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000495	0.00093	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000495	0.00093	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000493	0.000927	CcSEcCtD
Epoprostenol—Tachycardia—Betamethasone—rheumatoid arthritis	0.000493	0.000927	CcSEcCtD
Epoprostenol—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00049	0.000922	CcSEcCtD
Epoprostenol—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00049	0.000921	CcSEcCtD
Epoprostenol—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000489	0.000919	CcSEcCtD
Epoprostenol—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000489	0.000918	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000489	0.000918	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000484	0.000909	CcSEcCtD
Epoprostenol—Syncope—Prednisone—rheumatoid arthritis	0.000484	0.000909	CcSEcCtD
Epoprostenol—Anorexia—Betamethasone—rheumatoid arthritis	0.000482	0.000905	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—rheumatoid arthritis	0.000482	0.000905	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—rheumatoid arthritis	0.000481	0.000904	CcSEcCtD
Epoprostenol—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000481	0.000903	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—rheumatoid arthritis	0.00048	0.000902	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000479	0.0009	CcSEcCtD
Epoprostenol—Asthenia—Cyclosporine—rheumatoid arthritis	0.000478	0.000897	CcSEcCtD
Epoprostenol—Pain—Triamcinolone—rheumatoid arthritis	0.000476	0.000895	CcSEcCtD
Epoprostenol—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000474	0.000891	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—rheumatoid arthritis	0.000472	0.000887	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—rheumatoid arthritis	0.000472	0.000887	CcSEcCtD
Epoprostenol—Pruritus—Cyclosporine—rheumatoid arthritis	0.000471	0.000885	CcSEcCtD
Epoprostenol—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00047	0.000883	CcSEcCtD
Epoprostenol—Angiopathy—Methotrexate—rheumatoid arthritis	0.00047	0.000883	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000468	0.000879	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000468	0.000879	CcSEcCtD
Epoprostenol—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000467	0.000877	CcSEcCtD
Epoprostenol—Chills—Methotrexate—rheumatoid arthritis	0.000465	0.000873	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.00046	0.000865	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.00046	0.000865	CcSEcCtD
Epoprostenol—Arthralgia—Prednisone—rheumatoid arthritis	0.000459	0.000863	CcSEcCtD
Epoprostenol—Myalgia—Prednisone—rheumatoid arthritis	0.000459	0.000863	CcSEcCtD
Epoprostenol—Anxiety—Prednisone—rheumatoid arthritis	0.000458	0.00086	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—rheumatoid arthritis	0.000457	0.000859	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—rheumatoid arthritis	0.000457	0.000859	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000456	0.000857	CcSEcCtD
Epoprostenol—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000455	0.000856	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000454	0.000854	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000454	0.000853	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000454	0.000853	CcSEcCtD
Epoprostenol—Mental disorder—Methotrexate—rheumatoid arthritis	0.000454	0.000852	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000446	0.000839	CcSEcCtD
Epoprostenol—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000445	0.000836	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000445	0.000836	CcSEcCtD
Epoprostenol—Urticaria—Triamcinolone—rheumatoid arthritis	0.000443	0.000832	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000442	0.00083	CcSEcCtD
Epoprostenol—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00044	0.000827	CcSEcCtD
Epoprostenol—Dizziness—Cyclosporine—rheumatoid arthritis	0.00044	0.000827	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.00044	0.000827	CcSEcCtD
Epoprostenol—Oedema—Prednisone—rheumatoid arthritis	0.00044	0.000827	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000439	0.000826	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000439	0.000826	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000439	0.000826	CcSEcCtD
Epoprostenol—Infection—Prednisone—rheumatoid arthritis	0.000437	0.000822	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000436	0.00082	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000436	0.00082	CcSEcCtD
Epoprostenol—Back pain—Methotrexate—rheumatoid arthritis	0.000436	0.000819	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000436	0.000819	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—rheumatoid arthritis	0.000436	0.000819	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—rheumatoid arthritis	0.000436	0.000819	CcSEcCtD
Epoprostenol—Shock—Prednisone—rheumatoid arthritis	0.000433	0.000814	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—rheumatoid arthritis	0.000432	0.000812	CcSEcCtD
Epoprostenol—Pain—Betamethasone—rheumatoid arthritis	0.000432	0.000812	CcSEcCtD
Epoprostenol—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000432	0.000811	CcSEcCtD
Epoprostenol—Tachycardia—Prednisone—rheumatoid arthritis	0.00043	0.000807	CcSEcCtD
Epoprostenol—Skin disorder—Prednisone—rheumatoid arthritis	0.000428	0.000803	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000426	0.0008	CcSEcCtD
Epoprostenol—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000424	0.000798	CcSEcCtD
Epoprostenol—Vomiting—Cyclosporine—rheumatoid arthritis	0.000423	0.000795	CcSEcCtD
Epoprostenol—Rash—Cyclosporine—rheumatoid arthritis	0.00042	0.000789	CcSEcCtD
Epoprostenol—Anorexia—Prednisone—rheumatoid arthritis	0.00042	0.000788	CcSEcCtD
Epoprostenol—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000419	0.000788	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000419	0.000787	CcSEcCtD
Epoprostenol—Headache—Cyclosporine—rheumatoid arthritis	0.000417	0.000784	CcSEcCtD
Epoprostenol—Anaemia—Methotrexate—rheumatoid arthritis	0.000417	0.000783	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000413	0.000777	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000413	0.000777	CcSEcCtD
Epoprostenol—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00041	0.000771	CcSEcCtD
Epoprostenol—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000409	0.000769	CcSEcCtD
Epoprostenol—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000405	0.000761	CcSEcCtD
Epoprostenol—Urticaria—Betamethasone—rheumatoid arthritis	0.000402	0.000755	CcSEcCtD
Epoprostenol—Urticaria—Dexamethasone—rheumatoid arthritis	0.000402	0.000755	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000401	0.000754	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—rheumatoid arthritis	0.000401	0.000753	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—rheumatoid arthritis	0.0004	0.000751	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—rheumatoid arthritis	0.0004	0.000751	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.0004	0.000751	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—rheumatoid arthritis	0.0004	0.000751	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.0004	0.000751	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000399	0.000749	CcSEcCtD
Epoprostenol—Insomnia—Prednisone—rheumatoid arthritis	0.000398	0.000748	CcSEcCtD
Epoprostenol—Nausea—Cyclosporine—rheumatoid arthritis	0.000395	0.000743	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisone—rheumatoid arthritis	0.000395	0.000743	CcSEcCtD
Epoprostenol—Pruritus—Triamcinolone—rheumatoid arthritis	0.000394	0.000741	CcSEcCtD
Epoprostenol—Cough—Methotrexate—rheumatoid arthritis	0.000393	0.000739	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000393	0.000739	CcSEcCtD
Epoprostenol—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000391	0.000735	CcSEcCtD
Epoprostenol—Dyspepsia—Prednisone—rheumatoid arthritis	0.000387	0.000728	CcSEcCtD
Epoprostenol—Myalgia—Methotrexate—rheumatoid arthritis	0.000384	0.000721	CcSEcCtD
Epoprostenol—Chest pain—Methotrexate—rheumatoid arthritis	0.000384	0.000721	CcSEcCtD
Epoprostenol—Arthralgia—Methotrexate—rheumatoid arthritis	0.000384	0.000721	CcSEcCtD
Epoprostenol—Decreased appetite—Prednisone—rheumatoid arthritis	0.000383	0.000719	CcSEcCtD
Epoprostenol—Rash—Prednisolone—rheumatoid arthritis	0.000382	0.000718	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—rheumatoid arthritis	0.000382	0.000717	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000381	0.000716	CcSEcCtD
Epoprostenol—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00038	0.000715	CcSEcCtD
Epoprostenol—Fatigue—Prednisone—rheumatoid arthritis	0.000379	0.000713	CcSEcCtD
Epoprostenol—Headache—Prednisolone—rheumatoid arthritis	0.000379	0.000713	CcSEcCtD
Epoprostenol—Constipation—Prednisone—rheumatoid arthritis	0.000376	0.000707	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000376	0.000707	CcSEcCtD
Epoprostenol—Rash—Hydrocortisone—rheumatoid arthritis	0.000373	0.000701	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000373	0.0007	CcSEcCtD
Epoprostenol—Confusional state—Methotrexate—rheumatoid arthritis	0.000371	0.000697	CcSEcCtD
Epoprostenol—Headache—Hydrocortisone—rheumatoid arthritis	0.000371	0.000696	CcSEcCtD
Epoprostenol—Dizziness—Triamcinolone—rheumatoid arthritis	0.000368	0.000692	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000368	0.000691	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000368	0.000691	CcSEcCtD
Epoprostenol—Infection—Methotrexate—rheumatoid arthritis	0.000365	0.000687	CcSEcCtD
Epoprostenol—Asthenia—Dexamethasone—rheumatoid arthritis	0.000363	0.000681	CcSEcCtD
Epoprostenol—Asthenia—Betamethasone—rheumatoid arthritis	0.000363	0.000681	CcSEcCtD
Epoprostenol—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000361	0.000678	CcSEcCtD
Epoprostenol—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.00036	0.000677	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00036	0.000676	CcSEcCtD
Epoprostenol—Nausea—Prednisolone—rheumatoid arthritis	0.00036	0.000676	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—rheumatoid arthritis	0.000358	0.000672	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—rheumatoid arthritis	0.000358	0.000672	CcSEcCtD
Epoprostenol—Skin disorder—Methotrexate—rheumatoid arthritis	0.000357	0.000671	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000356	0.000668	CcSEcCtD
Epoprostenol—Vomiting—Triamcinolone—rheumatoid arthritis	0.000354	0.000666	CcSEcCtD
Epoprostenol—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000353	0.000664	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—rheumatoid arthritis	0.000351	0.00066	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—rheumatoid arthritis	0.000351	0.00066	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000351	0.000659	CcSEcCtD
Epoprostenol—Anorexia—Methotrexate—rheumatoid arthritis	0.000351	0.000659	CcSEcCtD
Epoprostenol—Rash—Methylprednisolone—rheumatoid arthritis	0.00035	0.000659	CcSEcCtD
Epoprostenol—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00035	0.000658	CcSEcCtD
Epoprostenol—Urticaria—Prednisone—rheumatoid arthritis	0.00035	0.000657	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—rheumatoid arthritis	0.000349	0.000656	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—rheumatoid arthritis	0.000348	0.000654	CcSEcCtD
Epoprostenol—Body temperature increased—Prednisone—rheumatoid arthritis	0.000348	0.000654	CcSEcCtD
Epoprostenol—Abdominal pain—Prednisone—rheumatoid arthritis	0.000348	0.000654	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000346	0.00065	CcSEcCtD
Epoprostenol—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000346	0.00065	CcSEcCtD
Epoprostenol—Hypotension—Methotrexate—rheumatoid arthritis	0.000344	0.000646	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000335	0.00063	CcSEcCtD
Epoprostenol—Dizziness—Dexamethasone—rheumatoid arthritis	0.000334	0.000628	CcSEcCtD
Epoprostenol—Dizziness—Betamethasone—rheumatoid arthritis	0.000334	0.000628	CcSEcCtD
Epoprostenol—Insomnia—Methotrexate—rheumatoid arthritis	0.000333	0.000625	CcSEcCtD
Epoprostenol—Nausea—Triamcinolone—rheumatoid arthritis	0.000331	0.000622	CcSEcCtD
Epoprostenol—Paraesthesia—Methotrexate—rheumatoid arthritis	0.00033	0.000621	CcSEcCtD
Epoprostenol—Nausea—Methylprednisolone—rheumatoid arthritis	0.00033	0.00062	CcSEcCtD
Epoprostenol—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000328	0.000616	CcSEcCtD
Epoprostenol—Somnolence—Methotrexate—rheumatoid arthritis	0.000327	0.000615	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000324	0.000609	CcSEcCtD
Epoprostenol—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000324	0.000608	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—rheumatoid arthritis	0.000321	0.000604	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—rheumatoid arthritis	0.000321	0.000604	CcSEcCtD
Epoprostenol—Decreased appetite—Methotrexate—rheumatoid arthritis	0.00032	0.000601	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—rheumatoid arthritis	0.000319	0.000599	CcSEcCtD
Epoprostenol—Rash—Betamethasone—rheumatoid arthritis	0.000319	0.000599	CcSEcCtD
Epoprostenol—Dermatitis—Betamethasone—rheumatoid arthritis	0.000318	0.000598	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000318	0.000598	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000318	0.000597	CcSEcCtD
Epoprostenol—Fatigue—Methotrexate—rheumatoid arthritis	0.000317	0.000596	CcSEcCtD
Epoprostenol—Headache—Dexamethasone—rheumatoid arthritis	0.000317	0.000595	CcSEcCtD
Epoprostenol—Headache—Betamethasone—rheumatoid arthritis	0.000317	0.000595	CcSEcCtD
Epoprostenol—Asthenia—Prednisone—rheumatoid arthritis	0.000316	0.000593	CcSEcCtD
Epoprostenol—Pain—Methotrexate—rheumatoid arthritis	0.000315	0.000591	CcSEcCtD
Epoprostenol—Pruritus—Prednisone—rheumatoid arthritis	0.000311	0.000585	CcSEcCtD
Epoprostenol—Diarrhoea—Prednisone—rheumatoid arthritis	0.000301	0.000566	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000301	0.000565	CcSEcCtD
Epoprostenol—Nausea—Dexamethasone—rheumatoid arthritis	0.0003	0.000564	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—rheumatoid arthritis	0.0003	0.000564	CcSEcCtD
Epoprostenol—Urticaria—Methotrexate—rheumatoid arthritis	0.000292	0.000549	CcSEcCtD
Epoprostenol—Dizziness—Prednisone—rheumatoid arthritis	0.000291	0.000547	CcSEcCtD
Epoprostenol—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000291	0.000546	CcSEcCtD
Epoprostenol—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000291	0.000546	CcSEcCtD
Epoprostenol—Vomiting—Prednisone—rheumatoid arthritis	0.00028	0.000526	CcSEcCtD
Epoprostenol—Rash—Prednisone—rheumatoid arthritis	0.000278	0.000522	CcSEcCtD
Epoprostenol—Dermatitis—Prednisone—rheumatoid arthritis	0.000277	0.000521	CcSEcCtD
Epoprostenol—Headache—Prednisone—rheumatoid arthritis	0.000276	0.000518	CcSEcCtD
Epoprostenol—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000271	0.000509	CcSEcCtD
Epoprostenol—Asthenia—Methotrexate—rheumatoid arthritis	0.000264	0.000496	CcSEcCtD
Epoprostenol—Nausea—Prednisone—rheumatoid arthritis	0.000261	0.000491	CcSEcCtD
Epoprostenol—Pruritus—Methotrexate—rheumatoid arthritis	0.00026	0.000489	CcSEcCtD
Epoprostenol—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000252	0.000473	CcSEcCtD
Epoprostenol—Dizziness—Methotrexate—rheumatoid arthritis	0.000243	0.000457	CcSEcCtD
Epoprostenol—Vomiting—Methotrexate—rheumatoid arthritis	0.000234	0.00044	CcSEcCtD
Epoprostenol—Rash—Methotrexate—rheumatoid arthritis	0.000232	0.000436	CcSEcCtD
Epoprostenol—Dermatitis—Methotrexate—rheumatoid arthritis	0.000232	0.000435	CcSEcCtD
Epoprostenol—Headache—Methotrexate—rheumatoid arthritis	0.00023	0.000433	CcSEcCtD
Epoprostenol—Nausea—Methotrexate—rheumatoid arthritis	0.000219	0.000411	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—C5—rheumatoid arthritis	0.000198	0.000426	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000198	0.000426	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000198	0.000426	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000198	0.000425	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000198	0.000425	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.000197	0.000424	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCF2—rheumatoid arthritis	0.000197	0.000424	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—C3—rheumatoid arthritis	0.000196	0.000423	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000195	0.000419	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000195	0.000419	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CCR5—rheumatoid arthritis	0.000194	0.000417	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000192	0.000413	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000192	0.000413	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—GZMB—rheumatoid arthritis	0.000191	0.00041	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CAT—rheumatoid arthritis	0.00019	0.000409	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTHFR—rheumatoid arthritis	0.000189	0.000407	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—HLA-A—rheumatoid arthritis	0.000189	0.000406	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	0.000187	0.000402	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	0.000187	0.000402	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000186	0.000401	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000186	0.000401	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR6—rheumatoid arthritis	0.000186	0.000401	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR6—rheumatoid arthritis	0.000186	0.000401	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000185	0.000398	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL3—rheumatoid arthritis	0.000185	0.000398	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000185	0.000398	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000185	0.000398	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—rheumatoid arthritis	0.000184	0.000396	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000184	0.000395	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000184	0.000395	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000183	0.000393	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000182	0.000392	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000182	0.000392	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCF2—rheumatoid arthritis	0.000181	0.00039	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCF2—rheumatoid arthritis	0.000181	0.00039	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SAA1—rheumatoid arthritis	0.000181	0.00039	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—C3—rheumatoid arthritis	0.000181	0.000389	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—C3—rheumatoid arthritis	0.000181	0.000389	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.00018	0.000387	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—C3—rheumatoid arthritis	0.000178	0.000384	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NCF1—rheumatoid arthritis	0.000177	0.000381	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000176	0.00038	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000176	0.00038	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000176	0.00038	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000176	0.00038	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—GZMB—rheumatoid arthritis	0.000175	0.000378	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000175	0.000378	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	0.000174	0.000374	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CD28—rheumatoid arthritis	0.00017	0.000367	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL3—rheumatoid arthritis	0.00017	0.000367	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL2—rheumatoid arthritis	0.00017	0.000367	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.00017	0.000367	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL3—rheumatoid arthritis	0.00017	0.000367	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—rheumatoid arthritis	0.000169	0.000364	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000168	0.000362	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000168	0.000362	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SAA1—rheumatoid arthritis	0.000167	0.000359	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SAA1—rheumatoid arthritis	0.000167	0.000359	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000166	0.000356	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000166	0.000356	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6ST—rheumatoid arthritis	0.000165	0.000356	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—C3—rheumatoid arthritis	0.000164	0.000353	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—C3—rheumatoid arthritis	0.000164	0.000353	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—rheumatoid arthritis	0.000164	0.000353	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NCF1—rheumatoid arthritis	0.000163	0.000351	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000163	0.000351	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.00016	0.000345	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD80—rheumatoid arthritis	0.000159	0.000343	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTHFR—rheumatoid arthritis	0.000158	0.000341	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000157	0.000339	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000157	0.000339	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000157	0.000338	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CD28—rheumatoid arthritis	0.000157	0.000338	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CD28—rheumatoid arthritis	0.000157	0.000338	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—VEGFA—rheumatoid arthritis	0.000156	0.000336	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000156	0.000336	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000156	0.000335	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	0.000152	0.000328	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000148	0.000318	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000148	0.000318	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6R—rheumatoid arthritis	0.000148	0.000318	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000147	0.000316	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SYK—rheumatoid arthritis	0.000146	0.000315	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000145	0.000312	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000145	0.000312	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000145	0.000312	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000145	0.000312	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000145	0.000311	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000145	0.000311	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—VEGFA—rheumatoid arthritis	0.000144	0.000309	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000144	0.000309	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000144	0.000309	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000144	0.000309	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—rheumatoid arthritis	0.000143	0.000309	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000143	0.000308	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000143	0.000308	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—POMC—rheumatoid arthritis	0.000143	0.000307	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	0.000141	0.000304	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT1—rheumatoid arthritis	0.000141	0.000304	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL2—rheumatoid arthritis	0.00014	0.0003	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000139	0.0003	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000139	0.000299	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000135	0.000291	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000135	0.000291	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SYK—rheumatoid arthritis	0.000135	0.00029	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SYK—rheumatoid arthritis	0.000135	0.00029	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TYK2—rheumatoid arthritis	0.000134	0.000289	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000132	0.000284	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000132	0.000284	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS3—rheumatoid arthritis	0.000132	0.000284	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—rheumatoid arthritis	0.000132	0.000284	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—POMC—rheumatoid arthritis	0.000131	0.000283	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000131	0.000283	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT1—rheumatoid arthritis	0.00013	0.000279	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT1—rheumatoid arthritis	0.00013	0.000279	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000128	0.000277	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000128	0.000277	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000128	0.000276	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000128	0.000276	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000128	0.000275	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000128	0.000275	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP3—rheumatoid arthritis	0.000127	0.000273	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000127	0.000273	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—POMC—rheumatoid arthritis	0.000127	0.000273	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTK2—rheumatoid arthritis	0.000122	0.000263	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—rheumatoid arthritis	0.000122	0.000262	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000122	0.000262	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTGS2—rheumatoid arthritis	0.000121	0.00026	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	0.00012	0.000258	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL5—rheumatoid arthritis	0.00012	0.000258	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—rheumatoid arthritis	0.000118	0.000254	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CSF2—rheumatoid arthritis	0.000118	0.000254	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	0.000117	0.000253	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP3—rheumatoid arthritis	0.000117	0.000251	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP3—rheumatoid arthritis	0.000117	0.000251	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000117	0.000251	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.000117	0.000251	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000116	0.00025	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—rheumatoid arthritis	0.000116	0.000249	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTK2—rheumatoid arthritis	0.000112	0.000242	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000112	0.000242	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000112	0.000241	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000112	0.000241	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SPP1—rheumatoid arthritis	0.000111	0.000239	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—NOS3—rheumatoid arthritis	0.000111	0.000238	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.00011	0.000238	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL5—rheumatoid arthritis	0.00011	0.000237	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL5—rheumatoid arthritis	0.00011	0.000237	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—rheumatoid arthritis	0.000109	0.000234	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CSF2—rheumatoid arthritis	0.000108	0.000234	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000108	0.000234	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—rheumatoid arthritis	0.000108	0.000232	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000107	0.00023	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000107	0.00023	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000106	0.000229	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—rheumatoid arthritis	0.000105	0.000227	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—C3—rheumatoid arthritis	0.000105	0.000227	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000102	0.00022	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SPP1—rheumatoid arthritis	0.000102	0.00022	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000102	0.000219	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000102	0.000219	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTGS2—rheumatoid arthritis	0.000101	0.000218	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—rheumatoid arthritis	9.92e-05	0.000214	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—rheumatoid arthritis	9.92e-05	0.000214	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LEP—rheumatoid arthritis	9.81e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2RA—rheumatoid arthritis	9.78e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2RA—rheumatoid arthritis	9.78e-05	0.000211	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—rheumatoid arthritis	9.71e-05	0.000209	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—rheumatoid arthritis	9.71e-05	0.000209	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—C3—rheumatoid arthritis	9.7e-05	0.000209	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—C3—rheumatoid arthritis	9.7e-05	0.000209	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	9.42e-05	0.000203	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FN1—rheumatoid arthritis	9.25e-05	0.000199	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6ST—rheumatoid arthritis	9.21e-05	0.000198	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	9.1e-05	0.000196	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—rheumatoid arthritis	9.03e-05	0.000194	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—rheumatoid arthritis	9.03e-05	0.000194	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CD80—rheumatoid arthritis	8.87e-05	0.000191	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—rheumatoid arthritis	8.73e-05	0.000188	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	8.56e-05	0.000184	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—FN1—rheumatoid arthritis	8.51e-05	0.000183	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FN1—rheumatoid arthritis	8.51e-05	0.000183	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6ST—rheumatoid arthritis	8.48e-05	0.000183	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6ST—rheumatoid arthritis	8.48e-05	0.000183	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—rheumatoid arthritis	8.43e-05	0.000181	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	8.32e-05	0.000179	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GC—rheumatoid arthritis	8.32e-05	0.000179	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—rheumatoid arthritis	8.24e-05	0.000178	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6R—rheumatoid arthritis	8.22e-05	0.000177	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CD80—rheumatoid arthritis	8.16e-05	0.000176	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CD80—rheumatoid arthritis	8.16e-05	0.000176	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—rheumatoid arthritis	7.76e-05	0.000167	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—rheumatoid arthritis	7.76e-05	0.000167	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	7.74e-05	0.000167	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—rheumatoid arthritis	7.59e-05	0.000163	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—rheumatoid arthritis	7.59e-05	0.000163	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6R—rheumatoid arthritis	7.56e-05	0.000163	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6R—rheumatoid arthritis	7.56e-05	0.000163	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TYK2—rheumatoid arthritis	7.49e-05	0.000161	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—rheumatoid arthritis	7.35e-05	0.000158	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TYK2—rheumatoid arthritis	6.89e-05	0.000148	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TYK2—rheumatoid arthritis	6.89e-05	0.000148	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MED1—rheumatoid arthritis	6.79e-05	0.000146	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—rheumatoid arthritis	6.76e-05	0.000146	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—rheumatoid arthritis	6.76e-05	0.000146	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—rheumatoid arthritis	6.57e-05	0.000142	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—rheumatoid arthritis	6.52e-05	0.00014	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	6.31e-05	0.000136	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	6.31e-05	0.000136	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—rheumatoid arthritis	6.23e-05	0.000134	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—rheumatoid arthritis	6.2e-05	0.000133	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—rheumatoid arthritis	6e-05	0.000129	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—rheumatoid arthritis	6e-05	0.000129	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—rheumatoid arthritis	5.9e-05	0.000127	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKB1—rheumatoid arthritis	5.83e-05	0.000126	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—rheumatoid arthritis	5.73e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—rheumatoid arthritis	5.73e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—rheumatoid arthritis	5.73e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—rheumatoid arthritis	5.7e-05	0.000123	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—rheumatoid arthritis	5.7e-05	0.000123	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BGN—rheumatoid arthritis	5.68e-05	0.000122	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—rheumatoid arthritis	5.43e-05	0.000117	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—rheumatoid arthritis	5.43e-05	0.000117	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKB1—rheumatoid arthritis	5.37e-05	0.000116	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKB1—rheumatoid arthritis	5.37e-05	0.000116	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—VEGFA—rheumatoid arthritis	5.29e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—rheumatoid arthritis	5.28e-05	0.000114	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—rheumatoid arthritis	5.28e-05	0.000114	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	5.23e-05	0.000113	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.87e-05	0.000105	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—VEGFA—rheumatoid arthritis	4.87e-05	0.000105	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—rheumatoid arthritis	4.86e-05	0.000105	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.6e-05	9.9e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—rheumatoid arthritis	4.47e-05	9.63e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.47e-05	9.63e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	4.26e-05	9.18e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.19e-05	9.02e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—rheumatoid arthritis	4e-05	8.61e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—rheumatoid arthritis	3.68e-05	7.93e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—rheumatoid arthritis	3.68e-05	7.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.67e-05	7.9e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—rheumatoid arthritis	3.66e-05	7.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—rheumatoid arthritis	3.37e-05	7.26e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—rheumatoid arthritis	3.37e-05	7.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAT—rheumatoid arthritis	3.07e-05	6.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.56e-05	5.51e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—rheumatoid arthritis	2.05e-05	4.41e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.87e-05	4.02e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.79e-05	3.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.63e-05	3.52e-05	CbGpPWpGaD
